Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

China’s Immune Therapy Stocks Soar as Research Delivers Promising Results

Daniel Kim Views  

Baidu AI

Chinese immunotherapy stocks are leading the rebound in the Chinese stock market with a 10-day consecutive rise.

On the morning of the 9th, Guan Hao Biology (冠昊生物 300238.SZ) and Canature Health Technology (开能健康 300272.SZ) surged over 20% as soon as the market opened. Zhongyuan Xiehe (中源协和 600645.SH) and Guizhou Chitianhua (赤天化 600227.SH) also showed strong performance with a sharp rise.

Immunotherapy refers to achieving therapeutic goals by attacking diseased cells with the patient’s immune system. Recently, significant progress has been reported in immunotherapy research in China.

Professor Zhang Lei and Professor Yang Renchi’s team at the Institute of Hematology and Blood Diseases of the Chinese Academy of Medical Sciences in Shanghai announced the results of a prospective study on the efficacy and safety of mesenchymal stem cells in the treatment of immune thrombocytopenia (ITP).

The study confirmed that mesenchymal stem cells are effective and safe for refractory ITP and provided a new treatment method.

Researchers Zhang Xiaoming from the Shanghai Institute of Immunity and Infection of the Chinese Academy of Sciences, Professor Gao Qiang, and Professor Fan Jia from the Zhongshan Hospital affiliated with Fudan University published a research paper titled “A blueprint for tumor-infiltrating B cells across human cancers” in Science. In this paper, the research team revealed two reaction patterns of tumor infiltration of B cells and their impact on tumor immunity.

According to data from the American research company Frost & Sullivan, there are over 500 million autoimmune disease patients worldwide, with approximately 40 million in China.

Accordingly, China’s autoimmune therapeutics market is expected to reach $8.7 billion by 2025. China’s autoimmune disorders treatment market is experiencing rapid growth, with an average annual growth rate of 28.1%.

Meanwhile, last year, Loqtorzi, an immunotherapy drug developed by Junshi Biosciences (君實生物 688180.SS) in Shanghai, China, received approval from the U.S. Food and Drug Administration (FDA).

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[BUSINESS] Latest Stories

  • Nancy Pelosi's Husband Strikes Gold with Nvidia Options
  • Samsung Workers Strike for the First Time: A Historic Labor Showdown
  • Strike Alert! Canada's Second-Largest Copper Mine Faces Shutdown
  • UAE President Pledges $30 Billion Investment in South Korea
  • Elon Musk's Latest AI Project Attracts $6 Billion, Signaling Major Industry Shift
  • China Chooses iPhone: Apple's Smart Strategy Leads to a 52% Sales Increase

Weekly Best Articles

  • Nancy Pelosi’s Husband Strikes Gold with Nvidia Options
  • China and Russia Join Hands and Issues Warning Over U.S. Military Space Dominance
  • Historic Mission: Chang’e-6 Set to Collect First-Ever Samples from Moon’s Dark Side
  • North Korea Sends ‘Filth Balloons’ into South Korean Territory: A Violation of the Armistice Agreement?
  • North Korea’s GPS Jamming and Missile Launches, Provocations Escalate
  • ILLIT’s ‘Magnetic’ Keeps Pulling Fans: Continues Its Hot Streak on Billboard and Spotify
  • Kim Jong Un’s Sister Mocks South Korea with Trash-Filled Balloons: Border Showdown Imminent?
  • Samsung Workers Strike for the First Time: A Historic Labor Showdown
  • Strike Alert! Canada’s Second-Largest Copper Mine Faces Shutdown
  • NCT Jaehyun Joins Lauv As Special Guest at Seoul Jazz Festival 2024
  • North Korea Fires Over 10 Missiles into the Sea of Japan, Seoul on High Alert
  • NewJeans Joins Beyoncé and Adele Among ‘The Face’s Legendary Cover Stars

You May Also Like

  • 1
    Emergency Alerts Issued in Seoul Amid North Korean Flyer Scare

    ASIA 

  • 2
    Colombia's Search for $20 Billion in Sunken Spanish Gold

    LATEST 

  • 3
    House of 'Home Alone' Hits the Market: Live Like Kevin for $5.25 Million!

    LATEST 

  • 4
    North Korea's Kim Encourages Scientists Post-Failure: 'Do Not Be Dismayed'

    ASIA 

  • 5
    Calls for Military Reform Intensify After Soldier's Death

    ASIA 

Popular Now

  • 1
    Three European Countries Recognize Palestine Statehood

    WORLD 

  • 2
    Behind Closed Doors: How Israel Allegedly Manipulated International Justice

    WORLD 

  • 3
    Fruit Fury: Koreans Outraged Over Cheap U.S. Apple Prices

    LATEST 

  • 4
    Chinese Influencer Accuses Korea of Cultural Theft

    ENTERTAINMENT 

  • 5
    Drama Off-Screen: KBS Bans Appearances of Convicted Squid Game Actor O Yeong Su

    ENTERTAINMENT 

Weekly Best Articles

  • Nancy Pelosi’s Husband Strikes Gold with Nvidia Options
  • China and Russia Join Hands and Issues Warning Over U.S. Military Space Dominance
  • Historic Mission: Chang’e-6 Set to Collect First-Ever Samples from Moon’s Dark Side
  • North Korea Sends ‘Filth Balloons’ into South Korean Territory: A Violation of the Armistice Agreement?
  • North Korea’s GPS Jamming and Missile Launches, Provocations Escalate
  • ILLIT’s ‘Magnetic’ Keeps Pulling Fans: Continues Its Hot Streak on Billboard and Spotify
  • Kim Jong Un’s Sister Mocks South Korea with Trash-Filled Balloons: Border Showdown Imminent?
  • Samsung Workers Strike for the First Time: A Historic Labor Showdown
  • Strike Alert! Canada’s Second-Largest Copper Mine Faces Shutdown
  • NCT Jaehyun Joins Lauv As Special Guest at Seoul Jazz Festival 2024
  • North Korea Fires Over 10 Missiles into the Sea of Japan, Seoul on High Alert
  • NewJeans Joins Beyoncé and Adele Among ‘The Face’s Legendary Cover Stars

Must-Reads

  • 1
    Emergency Alerts Issued in Seoul Amid North Korean Flyer Scare

    ASIA 

  • 2
    Colombia's Search for $20 Billion in Sunken Spanish Gold

    LATEST 

  • 3
    House of 'Home Alone' Hits the Market: Live Like Kevin for $5.25 Million!

    LATEST 

  • 4
    North Korea's Kim Encourages Scientists Post-Failure: 'Do Not Be Dismayed'

    ASIA 

  • 5
    Calls for Military Reform Intensify After Soldier's Death

    ASIA 

Popular Now

  • 1
    Three European Countries Recognize Palestine Statehood

    WORLD 

  • 2
    Behind Closed Doors: How Israel Allegedly Manipulated International Justice

    WORLD 

  • 3
    Fruit Fury: Koreans Outraged Over Cheap U.S. Apple Prices

    LATEST 

  • 4
    Chinese Influencer Accuses Korea of Cultural Theft

    ENTERTAINMENT 

  • 5
    Drama Off-Screen: KBS Bans Appearances of Convicted Squid Game Actor O Yeong Su

    ENTERTAINMENT 

Share it on...